Related Experiment Videos
Should the Centers for Disease Control and Prevention's childhood lead poisoning intervention level be lowered?
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. sbernard@jhsph.edu
Insights
The US Centers for Disease Control and Prevention (CDC) screening level for childhood lead exposure remains 10 micro g/dL. However, prevention efforts can be enhanced through improved testing schedules and universal education for lead poisoning risks.
Area of Science:
- Environmental Health
- Pediatric Public Health
- Toxicology
Background:
- The US Centers for Disease Control and Prevention (CDC) established a 10 micro g/dL blood lead level (BLL) as an initial screening benchmark in 1991.
- Current scientific understanding of lead's health risks and available interventions does not substantiate a general reduction of this screening level.
Purpose of the Study:
- To evaluate the current screening level for lead in children's blood.
- To identify areas for improvement in federal lead poisoning prevention strategies.
Main Methods:
- Analysis of current data on health risks associated with lead exposure.
- Review of existing intervention options for lead poisoning.
- Assessment of current federal lead poisoning prevention efforts.
Main Results:
- Existing data do not support lowering the 10 micro g/dL screening level for lead in children's blood.
- Improvements in federal lead poisoning prevention can be achieved through revised follow-up testing schedules for infants (≤1 year) with BLLs ≥5 micro g/dL.
- Universal education on lead exposure risks and validated risk-screening questionnaires are recommended.
Conclusions:
- The current screening level of 10 micro g/dL for childhood lead exposure is maintained based on available data.
- Enhancing federal lead poisoning prevention requires a multi-faceted approach including revised testing protocols, universal education, improved screening tools, and updated regulatory criteria for primary prevention.
Abstract:
The US Centers for Disease Control and Prevention (CDC) in 1991 chose 10 micro g/dL as an initial screening level for lead in children's blood. Current data on health risks and intervention options do not support generally lowering that level, but federal lead poisoning prevention efforts can be improved by revising the follow-up testing schedule for infants aged 1 year or less with blood lead levels of 5 micro g/dL or higher; universal education about lead exposure risks; universal administration of improved, locally validated risk-screening questionnaires; enhanced compliance with targeted screening recommendations and federal health program requirements; and development by regulatory agencies of primary prevention criteria that do not use the CDC's intervention level as a target "safe" lead exposure.